Health Catalyst (HCAT) Receivables - Net (2018 - 2026)

Health Catalyst's Receivables - Net history runs 9 years deep, the most recent figure standing at $59.1 million for Q1 2026.

• Quarterly Receivables - Net fell 7.65% year-over-year to $59.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $59.1 million (down 7.65% YoY) and the FY2025 annual result came in at $59.1 million, up 3.4% from the prior year.
• Receivables - Net was $59.1 million for Q1 2026 at Health Catalyst, roughly flat from $59.1 million in the prior quarter.
• Across five years, Receivables - Net topped out at $68.4 million in Q2 2025 and bottomed at $42.6 million in Q1 2022.
• A 5-year average of $55.1 million and a median of $54.9 million in 2024 frame the typical range for Receivables - Net.
• Annual changes were most pronounced in 2023 — Receivables - Net surged 45.12% — and 2024, when it retreated 12.91%.
• Health Catalyst's Receivables - Net stood at $48.0 million in 2022, then increased by 25.68% to $60.3 million in 2023, then dropped by 5.16% to $57.2 million in 2024, then grew by 3.4% to $59.1 million in 2025, then grew by 0.03% to $59.1 million in 2026.
• Business Quant data shows HCAT's Receivables - Net at $59.1 million in Q1 2026, $59.1 million in Q4 2025, and $60.1 million in Q3 2025.